# Effect of Evolocumab on Coronary Plaque Characteristics

> **NCT04710368** · PHASE4 · COMPLETED · sponsor: **Annapoorna Kini** · enrollment: 137 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Evolocumab Injections

## Key facts

- **NCT ID:** NCT04710368
- **Lead sponsor:** Annapoorna Kini
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-04
- **Primary completion:** 2022-10-28
- **Final completion:** 2023-11-06
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04710368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04710368, "Effect of Evolocumab on Coronary Plaque Characteristics". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04710368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*